CDF

Akum Obtains CDSCO Panel to Manufacture, Commercialize Glimepiride and Lobeglitazone FDC

by

New Delhi: Pharmaceutical major Akum Pharmaceuticals has received the green signal from the Committee of Subject Matter Experts (SEC) functional under the Central Drug Standards Control Organization (CDSCO) to manufacture and market the Fixed Dose Combination (FDC) of the anti-diabetic medicine Glimepiride plus Lobeglitazone sulphate tablet. This came after the company presented the FDC Glimepiride … Read more

Health Bulletin 29/October/2022

by

Here are the main health news of the day: NMC warns against illegal MBBS and other medical courses at Singhania University Taking serious notice of the unauthorized MBBS and other medical courses offered by Singhania University this academic year, the National Medical Commission (NMC) has issued an alert warning medical aspirants of the mischievous claim … Read more

NPPA Panel Suggests Retail Price of Atorvastatin, Bempedoic Acid FDC marketed by Zydus Healthcare

by

NPPA Panel Suggests Retail Price of Atorvastatin, Bempedoic Acid FDC marketed by Zydus Healthcare We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To find out more, see our Cookie Policy and Cookie Settings.Ok